Real-World watch: timing of myeloma relapse under the microscope
NCT ID NCT04985643
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study observes 357 people with multiple myeloma to see how long it takes for the disease to come back after their first treatment. Participants visit their clinic every 3 months and receive standard care. The goal is to better understand relapse timing in real-life practice, without testing any new treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Altai Regional Clinical Hospital
Barnaul, Altayskiy Kray, 656024, Russia
-
BaltikMed Clinic
Kaliningrad, Northwestern Federal District, 238022, Russia
-
City Clinical Hospital No. 1 named after prof. S.I.Sergeev
Khabarovsk, Far Eastern Federal District, 680009, Russia
-
City Clinical Hospital No. 12
Nizhny Novgorod, Volga Federal District, 603003, Russia
-
City Clinical Hospital No. 31
Saint Petersburg, Sankt-Peterburg, 197110, Russia
-
Clinic Akademicheskaya LLC
Volgograd, Volgogradskaya District, 400001, Russia
-
District Clinical Hospital
Khanty-Mansiysk, Tyumen Oblast, 628012, Russia
-
GUZ "Lipetsk City Hospital No. 3" Free Falcon "
Lipetsk, Lipetsk Oblast, 398007, Russia
-
Herzen Moscow Scientific Research Oncological Institute
Moscow, Moscow Oblast, 125284, Russia
-
Kaluga Regional Clinical Hospital
Kaluga, Central Federal District, 248007, Russia
-
Kirov Research Institute of Hematology and Blood Transfusion
Kirov, Kirov Oblast, 610027, Russia
-
Moscow Regional Research Clinical Institute n.a. M.F. Vladimirsky
Moscow, Moscow Oblast, 129110, Russia
-
National Research Center of Hematology of the Ministry of Health
Moscow, Moscow Oblast, 125167, Russia
-
Novosibirsk State Medical University, Department of Therapy, Hematology and Transfusiology based on City Clinical Hospital No. 2
Novosibirsk, Novosibirsk Oblast, 630051, Russia
-
Orenburgskaya Regional Clinical Hospital n.a. V.I. Voinova
Orenburg, Orenburgskaya District, 460018, Russia
-
Razumovskiy Saratov State Medical University, University Clinical
Saratov, Saratov Oblast, 410028, Russia
-
Republican Clinical Hospital named after G.G. Kuvatov
Ufa, 450005, Russia
-
Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan
Kazan', Republic Tatarstan, 420064, Russia
-
Republican hospital named after V.A.Baranov
Petrozavodsk, Republic of Karelia, 185019, Russia
-
Smolensk Clinical Hospital of Russian Railways-Medicine
Smolensk, Central Federal District, 214025, Russia
-
Surgut Regional Clinical Hospital
Surgut, Tyumen Oblast, 628408, Russia
-
Tomsk Regional Clinical Hospital
Tomsk, Siberian Federal District, 634063, Russia
-
Ulyanovsk Regional Clinical Hospital
Ulyanovsk, Ulyanovsk Oblast, 432017, Russia
-
Vologda Regional Clinical Hospital
Vologda, Northwestern Federal District, 160002, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact